Jefferies Group's WST Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 38,745 shares of West Pharmaceutical Services, Inc. (WST) worth $10.16 M, representing 0.05% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 11 quarters.
Based on 13F filings, Jefferies Group has maintained a strategic position in WST, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 25,845 shares. Largest reduction occurred in Q1 2025, reducing 14,814 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's West Pharmaceutical Services (WST) Holding Value Over Time
Track share changes against reported price movement
Quarterly West Pharmaceutical Services (WST) Trades by Jefferies Group
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2023 | +4,800 | New Buy | 4,800 | $346.47 |
| Q2 2023 | -1,920 | Reduce 40.00% | 2,880 | $382.47 |
| Q3 2023 | +5,520 | Add 191.67% | 8,400 | $375.21 |
| Q4 2023 | +1,300 | Add 15.48% | 9,700 | $352.12 |
| Q1 2024 | +2,005 | Add 20.67% | 11,705 | $395.71 |
| Q2 2024 | -9,022 | Reduce 77.08% | 2,683 | $329.39 |
| Q3 2024 | +5,498 | Add 204.92% | 8,181 | $300.16 |
| Q4 2024 | +25,845 | Add 315.91% | 34,026 | $327.56 |
| Q1 2025 | -14,814 | Reduce 43.54% | 19,212 | $223.88 |
| Q2 2025 | +18,033 | Add 93.86% | 37,245 | $218.80 |
| Q3 2025 | +1,500 | Add 4.03% | 38,745 | $262.33 |
Jefferies Group's West Pharmaceutical Services Investment FAQs
Jefferies Group first purchased West Pharmaceutical Services, Inc. (WST) in Q1 2023, acquiring 4,800 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held West Pharmaceutical Services, Inc. (WST) for 11 quarters since Q1 2023. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's largest addition to West Pharmaceutical Services, Inc. (WST) was in Q4 2024, adding 34,026 shares worth $11.15 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Jefferies Group's firm, Jefferies Financial Group Inc., owns 38,745 shares of West Pharmaceutical Services, Inc. (WST), valued at approximately $10.16 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, West Pharmaceutical Services, Inc. (WST) represents approximately 0.05% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group's peak holding in West Pharmaceutical Services, Inc. (WST) was 38,745 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.